1. Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes

   • Scott C. Thomson
   • Volker Vallon

   Microvascular Complications—Nephropathy (M Afkarian and B Roshanravan, Section Editors) 13 April 2018 Article: 28

2. New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors

   • Claire C. J. Dekkers
   • Ron T. Gansevoort
   • Hiddo J. L. Heerspink

   Microvascular Complications—Nephropathy (M Afkarian and B Roshanravan, Section Editors) Open access 27 March 2018 Article: 27

   

3. Hypoglycemia Prevention by Algorithm Design During Intravenous Insulin Infusion

   • Susan Shapiro Braithwaite
   • Lisa P. Clark
   • Oluwakemi T. Soetan

   Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors) 26 March 2018 Article: 26

   

4. Underutilized and Under Threat: Environmental Policy as a Tool to Address Diabetes Risk

   • Sabina Shaikh
   • Jyotsna S. Jagai
   • Robert M. Sargis

   Economics and Policy in Diabetes (ES Huang and AA Baig, Section Editors) 26 March 2018 Article: 25

   

5. A Narrative Review of Physician Perspectives Regarding the Social and Environmental Determinants of Obesity

   • Ashley H. Noriea
   • Feenalie N. Patel
   • Monica E. Peek

   Obesity (J McCaffery, Section Editor) 21 March 2018 Article: 24

6. Self- and Social-Regulation in Type 1 Diabetes Management During Late Adolescence and Emerging Adulthood

   • Deborah J. Wiebe
   • Cynthia A. Berg
   • Caitlin S. Kelly

   Psychosocial Aspects (SS Jaser, Section Editor) 21 March 2018 Article: 23

7. Renal Hyperfiltration in Adolescents with Type 2 Diabetes: Physiology, Sex Differences, and Implications for Diabetic Kidney Disease

   • Petter Bjornstad
   • David Z. Cherney

   Pediatric Type 2 and Monogenic Diabetes (PS Zeitler and O Pinhas-Hamiel, Section Editors) 19 March 2018 Article: 22